Skip to main content

Table 5 sTNFR-II and IL-8 levels in PNALT and HCC cases

From: Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

Cytokines (pg/ml)

PNALT, N = 17

HCC, N = 30

p-value

sTNFR-II ≥ 398

2 (11.8%)

22 (73%)

0.000

sTNFR-II < 398

15 (88.2%)

6 (27%)

0.000

IL-8 < 345

4 (23.5%)

29 (97%)

0.000

IL-8 ≥ 345

13 (76.5%)

1 (3.3%)

0.000

TNFR-II ≥ 398 or IL-8 <290. Either + ve

5 (29.4%)

30 (100%)

0.000

TNFR-II ≥ 398 and IL-8 <290. Both - ve

12 (70.6%)

0 (0%)

0.000

TNFR-II ≥ 398 and IL-8 <290. Both + ve

0 (0%)

21 (70%)

0.000

Others

17 (100%)

9 (30%)

0.000

  1. PNALT: chronic hepatitis C with persistent normal alanine aminotrasferase; HCC: hepatocellular carcinoma.